22157.jpg
Whole Exome Sequencing Market Research Report 2024-2034: Growing Role in Bioinformatics, Precision Medicine for Oncology, Impacts of AI
18 déc. 2024 07h11 HE | Research and Markets
Dublin, Dec. 18, 2024 (GLOBE NEWSWIRE) -- The "Whole Exome Sequencing Market - A Global and Regional Analysis: Focus on Product, Workflow, Application, End User, and Country - Analysis and Forecast,...
Artificial Intelligence (AI) in Drug Discovery Market
Artificial Intelligence (AI) in Drug Discovery Industry to Generate Revenues of $13.5 Billion in 2030 - Growing Use of AI for Drug Repurposing Expands Opportunities in Pharmaceutical Development
18 déc. 2024 04h02 HE | Research and Markets
Dublin, Dec. 18, 2024 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI) in Drug Discovery - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The...
MnM_logo_TM_JPG.JPG
AI in Precision Medicine Market to Hit US$ 3.92 Billion by 2030 with 30.7% CAGR | MarketsandMarkets™.
17 déc. 2024 07h30 HE | MarketsandMarkets Research Pvt. Ltd.
Delray Beach, FL, Dec. 17, 2024 (GLOBE NEWSWIRE) -- The global AI in precision medicine market is projected to reach USD 3.92 billion by 2030 from USD 0.78 billion in 2024, at a CAGR of 30.7% from...
XXXX.png
Silexion Therapeutics collaborates with Evonik on advanced siRNA Formulation Development
17 déc. 2024 06h30 HE | Silexion Therapeutics Corp
Cayman Islands, December 17, 2024 – Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven...
CRISPR and Cas Gene Market
Growth Trends in the CRISPR and Cas Gene Market: Industry Opportunities and Strategies to 2028 & 2033
13 déc. 2024 09h27 HE | Research and Markets
Dublin, Dec. 13, 2024 (GLOBE NEWSWIRE) -- The "CRISPR and Cas Gene Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering.This report describes and...
Precision Medicine Market
Precision Medicine Strategic Business Report 2024 - Growth of Direct-to-Consumer Genetic Testing Expands Opportunities for Precision Medicine in Preventive Healthcare - Forecasts to 2030
13 déc. 2024 08h51 HE | Research and Markets
Dublin, Dec. 13, 2024 (GLOBE NEWSWIRE) -- The "Precision Medicine - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Precision Medicine...
22157.jpg
Optical Genome Mapping Industry Research (2018-2033) Featuring Profiles of Agilent Technologies, Illumina, PerkinElmer Genomics, Bio-Rad Labs, Qiagen and Other Leading Players
11 déc. 2024 04h20 HE | Research and Markets
Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "Optical Genome Mapping Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. This report covers market...
XXXX.png
Silexion Therapeutics Appoints Renowned Cancer Therapeutics Expert Prof. Amnon Peled to Board of Directors
10 déc. 2024 08h30 HE | Silexion Therapeutics Corp
Cayman Islands, December 10, 2024 – Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven...
myriad_S_stacked.png
Myriad Genetics’ Portfolio Elevated by Updated NCCN Prostate Cancer Guidelines
10 déc. 2024 08h00 HE | Myriad Genetics, Inc.
Myriad Genetics’ full suite of urologic oncology products is elevated by updated NCCN prostate cancer guidelines.
Mind.Px™
Mindera Health™ Welcomes New Vice President of Sales
05 déc. 2024 08h00 HE | Mindera Health
Vista, CA, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Mindera Health, a pioneer in precision medicine combining machine learning with Next-Generation Sequencing to create Dermal Intelligence™, announces the...